Blockchain Registration Transaction Record

Tonix Pharmaceuticals to Present at World Vaccine Congress Washington 2025

Tonix Pharmaceuticals (NASDAQ: TNXP) to showcase TNX-102 SL for fibromyalgia management at World Vaccine Congress Washington 2025. Company also receives $34 million contract for antiviral development. Exciting advancements in biopharmaceuticals.

Tonix Pharmaceuticals to Present at World Vaccine Congress Washington 2025

This news highlights Tonix Pharmaceuticals' advancements in biopharmaceuticals, signaling potential breakthroughs in pain management and infectious disease treatment. Investors and individuals interested in innovative healthcare solutions should take note of Tonix's developments.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xb440ecdeb78f78f338eca86a3f6edb18157e46c3e7dfb2b3d8f68a1cc7506059
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprinttallNi3_-c2a94ed0d7023e9f75412cf734f27d85